Apnoea treatment fails to reduce risk in patients with ACS

Study questions the benefit of CPAP for secondary prevention

Treating obstructive sleep apnoea in patients with acute coronary syndrome may not reduce their risk of cardiovascular events, according to findings from a randomised controlled trial.